GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » US Neurosurgical Holding Inc (OTCPK:USNU) » Definitions » Cyclically Adjusted Price-to-FCF

USNU (US Neurosurgical Holding) Cyclically Adjusted Price-to-FCF : 5.20 (As of Dec. 15, 2024)


View and export this data going back to . Start your Free Trial

What is US Neurosurgical Holding Cyclically Adjusted Price-to-FCF?

As of today (2024-12-15), US Neurosurgical Holding's current share price is $0.7275. US Neurosurgical Holding's Cyclically Adjusted FCF per Share for the quarter that ended in Sep. 2024 was $0.14. US Neurosurgical Holding's Cyclically Adjusted Price-to-FCF for today is 5.20.

The historical rank and industry rank for US Neurosurgical Holding's Cyclically Adjusted Price-to-FCF or its related term are showing as below:

USNU' s Cyclically Adjusted Price-to-FCF Range Over the Past 10 Years
Min: 0.31   Med: 2.08   Max: 13.21
Current: 5.33

During the past years, US Neurosurgical Holding's highest Cyclically Adjusted Price-to-FCF was 13.21. The lowest was 0.31. And the median was 2.08.

USNU's Cyclically Adjusted Price-to-FCF is ranked better than
82.7% of 185 companies
in the Healthcare Providers & Services industry
Industry Median: 20.08 vs USNU: 5.33

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

US Neurosurgical Holding's adjusted free cash flow per share data for the three months ended in Sep. 2024 was $-0.004. Add all the adjusted free cash flow per share for the past 10 years together and divide 10 will get our Cyclically Adjusted FCF per Share, which is $0.14 for the trailing ten years ended in Sep. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


US Neurosurgical Holding Cyclically Adjusted Price-to-FCF Historical Data

The historical data trend for US Neurosurgical Holding's Cyclically Adjusted Price-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

US Neurosurgical Holding Cyclically Adjusted Price-to-FCF Chart

US Neurosurgical Holding Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted Price-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.40 1.94 1.63 0.93 3.50

US Neurosurgical Holding Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Cyclically Adjusted Price-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.61 3.50 5.89 4.50 4.11

Competitive Comparison of US Neurosurgical Holding's Cyclically Adjusted Price-to-FCF

For the Medical Care Facilities subindustry, US Neurosurgical Holding's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


US Neurosurgical Holding's Cyclically Adjusted Price-to-FCF Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, US Neurosurgical Holding's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where US Neurosurgical Holding's Cyclically Adjusted Price-to-FCF falls into.



US Neurosurgical Holding Cyclically Adjusted Price-to-FCF Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted Price-to-FCF takes the Free Cash Flow per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/FCF calculation. Because it considers this 10-year average, it's often referred to as the CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF.

US Neurosurgical Holding's Cyclically Adjusted Price-to-FCF for today is calculated as

Cyclically Adjusted Price-to-FCF=Share Price/ Cyclically Adjusted FCF per Share
=0.7275/0.14
=5.20

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

US Neurosurgical Holding's Cyclically Adjusted FCF per Share for the quarter that ended in Sep. 2024 is calculated as:

For example, US Neurosurgical Holding's adjusted Free Cash Flow per Share data for the three months ended in Sep. 2024 was:

Adj_FreeCashFlowPerShare=Free Cash Flow per Share/CPI of Sep. 2024 (Change)*Current CPI (Sep. 2024)
=-0.004/133.0289*133.0289
=-0.004

Current CPI (Sep. 2024) = 133.0289.

US Neurosurgical Holding Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201412 0.015 99.070 0.020
201503 0.033 99.621 0.044
201506 0.126 100.684 0.166
201509 0.016 100.392 0.021
201512 -0.027 99.792 -0.036
201603 0.093 100.470 0.123
201606 0.136 101.688 0.178
201609 0.013 101.861 0.017
201612 -0.004 101.863 -0.005
201703 0.229 102.862 0.296
201706 0.065 103.349 0.084
201709 0.030 104.136 0.038
201712 -0.022 104.011 -0.028
201803 0.085 105.290 0.107
201806 0.085 106.317 0.106
201809 0.062 106.507 0.077
201812 0.061 105.998 0.077
201903 0.058 107.251 0.072
201906 0.063 108.070 0.078
201909 0.018 108.329 0.022
201912 0.060 108.420 0.074
202003 0.097 108.902 0.118
202006 0.030 108.767 0.037
202009 -0.059 109.815 -0.071
202012 0.076 109.897 0.092
202103 0.027 111.754 0.032
202106 0.054 114.631 0.063
202109 -0.025 115.734 -0.029
202112 -0.034 117.630 -0.038
202203 -0.043 121.301 -0.047
202206 -0.073 125.017 -0.078
202209 -0.030 125.227 -0.032
202212 -0.034 125.222 -0.036
202303 -0.017 127.348 -0.018
202306 -0.078 128.729 -0.081
202309 0.022 129.860 0.023
202312 -0.024 129.419 -0.025
202403 -0.039 131.776 -0.039
202406 -0.034 132.554 -0.034
202409 -0.004 133.029 -0.004

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


US Neurosurgical Holding  (OTCPK:USNU) Cyclically Adjusted Price-to-FCF Explanation

Compared with the regular Price-to-Free-Cash-Flow, which works poorly for cyclical businesses, the Cyclically Adjusted Price-to-FCF smoothed out the fluctuations of free cash flow during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted Price-to-FCF should give similar results to regular Price-to-Free-Cash-Flow.


US Neurosurgical Holding Cyclically Adjusted Price-to-FCF Related Terms

Thank you for viewing the detailed overview of US Neurosurgical Holding's Cyclically Adjusted Price-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


US Neurosurgical Holding Business Description

Traded in Other Exchanges
N/A
Address
1131 W 6th Street, Ontario, CA, USA, 91672
US Neurosurgical Holding Inc operates as a holding company in the United States. It is a medical services company that partners with hospitals and physicians to operate facilities utilizing artistic and inventive technologies in medical treatment and diagnosis. It is engaged in providing medical treatment and diagnosis services that include stereotactic radiosurgery centers, utilizing gamma knife technology, and holds interests in radiological treatment facilities. The company is focusing on establishing cancer centers using intensity-modulated radiation therapy. Its gamma knife is a stereotactic radiosurgical device used to treat brain tumors and other malformations of the brain without invasive surgery.
Executives
Lawrence William St director 23 ASHLAND STREET, NEWBURYPORT MA 01950-1905
William F. Leimkuhler director 43 SALEM STRAITS RD, DARIEN CT 06820
Merriman Charles H Iii director
Alan Gold director, 10 percent owner, officer: President & Chairman 2400 RESEARCH BLVD, SUITE 325, ROCKVILLE MD 20850
Stanley S Shuman 10 percent owner C/O RIPPLEWOOD HOLDINGS LLC, ONE ROCKERFELLER PLAZA, NEW YORK NY 10020
Allen & Co Inc 10 percent owner 711 FIFTH AVENUE, NEW YORK NY 10022

US Neurosurgical Holding Headlines

No Headlines